The global market for Medicines for Alzheimer Disease Treatment was valued at US$ 15680 million in the year 2024 and is projected to reach a revised size of US$ 27200 million by 2031, growing at a CAGR of 8.3% during the forecast period.

Medicines for Alzheimer Disease Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medicines for Alzheimer Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicines for Alzheimer Disease Treatment.

The Medicines for Alzheimer Disease Treatment market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medicines for Alzheimer Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Medicines for Alzheimer Disease Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Medicines for Alzheimer Disease Treatment Market Report

Report Metric	Details
Report Name	Medicines for Alzheimer Disease Treatment Market
Accounted market size in year	US$ 15680 million
Forecasted market size in 2031	US$ 27200 million
CAGR	8.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	NMDA Receptor Antagonists Cholinesterase Inhibitors
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Daiichi Sankyo Company Limited, H. Lundbeck A/S, Novartis AG, Lupin Pharmaceuticals, Inc, Actiza Pharmaceutical Private Limited, Amneal Pharmaceuticals LLC, AC Immune, F. Hoffmann-La Roche Ltd, Janssen Global Services, LLC, AbbVie Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medicines for Alzheimer Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medicines for Alzheimer Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Medicines for Alzheimer Disease Treatment Market growing?

Ans: The Medicines for Alzheimer Disease Treatment Market witnessing a CAGR of 8.3% during the forecast period 2025-2031.

What is the Medicines for Alzheimer Disease Treatment Market size in 2031?

Ans: The Medicines for Alzheimer Disease Treatment Market size in 2031 will be US$ 27200 million.

Who are the main players in the Medicines for Alzheimer Disease Treatment Market report?

Ans: The main players in the Medicines for Alzheimer Disease Treatment Market are Daiichi Sankyo Company Limited, H. Lundbeck A/S, Novartis AG, Lupin Pharmaceuticals, Inc, Actiza Pharmaceutical Private Limited, Amneal Pharmaceuticals LLC, AC Immune, F. Hoffmann-La Roche Ltd, Janssen Global Services, LLC, AbbVie Inc

What are the Application segmentation covered in the Medicines for Alzheimer Disease Treatment Market report?

Ans: The Applications covered in the Medicines for Alzheimer Disease Treatment Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Medicines for Alzheimer Disease Treatment Market report?

Ans: The Types covered in the Medicines for Alzheimer Disease Treatment Market report are NMDA Receptor Antagonists, Cholinesterase Inhibitors

1 Medicines for Alzheimer Disease Treatment Market Overview

1.1 Product Definition

1.2 Medicines for Alzheimer Disease Treatment by Type

1.2.1 Global Medicines for Alzheimer Disease Treatment Market Value Comparison by Type (2024 VS 2031)

1.2.2 NMDA Receptor Antagonists

1.2.3 Cholinesterase Inhibitors

1.3 Medicines for Alzheimer Disease Treatment by Application

1.3.1 Global Medicines for Alzheimer Disease Treatment Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Global Medicines for Alzheimer Disease Treatment Market Size Estimates and Forecasts

1.4.1 Global Medicines for Alzheimer Disease Treatment Revenue 2020-2031

1.4.2 Global Medicines for Alzheimer Disease Treatment Sales 2020-2031

1.4.3 Global Medicines for Alzheimer Disease Treatment Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Medicines for Alzheimer Disease Treatment Market Competition by Manufacturers

2.1 Global Medicines for Alzheimer Disease Treatment Sales Market Share by Manufacturers (2020-2025)

2.2 Global Medicines for Alzheimer Disease Treatment Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Medicines for Alzheimer Disease Treatment Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Medicines for Alzheimer Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Medicines for Alzheimer Disease Treatment, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Medicines for Alzheimer Disease Treatment, Product Type & Application

2.7 Global Key Manufacturers of Medicines for Alzheimer Disease Treatment, Date of Enter into This Industry

2.8 Global Medicines for Alzheimer Disease Treatment Market Competitive Situation and Trends

2.8.1 Global Medicines for Alzheimer Disease Treatment Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Medicines for Alzheimer Disease Treatment Players Market Share by Revenue

2.8.3 Global Medicines for Alzheimer Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Medicines for Alzheimer Disease Treatment Market Scenario by Region

3.1 Global Medicines for Alzheimer Disease Treatment Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Medicines for Alzheimer Disease Treatment Sales by Region: 2020-2031

3.2.1 Global Medicines for Alzheimer Disease Treatment Sales by Region: 2020-2025

3.2.2 Global Medicines for Alzheimer Disease Treatment Sales by Region: 2026-2031

3.3 Global Medicines for Alzheimer Disease Treatment Revenue by Region: 2020-2031

3.3.1 Global Medicines for Alzheimer Disease Treatment Revenue by Region: 2020-2025

3.3.2 Global Medicines for Alzheimer Disease Treatment Revenue by Region: 2026-2031

3.4 North America Medicines for Alzheimer Disease Treatment Market Facts & Figures by Country

3.4.1 North America Medicines for Alzheimer Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Medicines for Alzheimer Disease Treatment Sales by Country (2020-2031)

3.4.3 North America Medicines for Alzheimer Disease Treatment Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Medicines for Alzheimer Disease Treatment Market Facts & Figures by Country

3.5.1 Europe Medicines for Alzheimer Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Medicines for Alzheimer Disease Treatment Sales by Country (2020-2031)

3.5.3 Europe Medicines for Alzheimer Disease Treatment Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Medicines for Alzheimer Disease Treatment Market Facts & Figures by Region

3.6.1 Asia Pacific Medicines for Alzheimer Disease Treatment Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Medicines for Alzheimer Disease Treatment Sales by Region (2020-2031)

3.6.3 Asia Pacific Medicines for Alzheimer Disease Treatment Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Medicines for Alzheimer Disease Treatment Market Facts & Figures by Country

3.7.1 Latin America Medicines for Alzheimer Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Medicines for Alzheimer Disease Treatment Sales by Country (2020-2031)

3.7.3 Latin America Medicines for Alzheimer Disease Treatment Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Medicines for Alzheimer Disease Treatment Market Facts & Figures by Country

3.8.1 Middle East and Africa Medicines for Alzheimer Disease Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Medicines for Alzheimer Disease Treatment Sales by Country (2020-2031)

3.8.3 Middle East and Africa Medicines for Alzheimer Disease Treatment Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Medicines for Alzheimer Disease Treatment Sales by Type (2020-2031)

4.1.1 Global Medicines for Alzheimer Disease Treatment Sales by Type (2020-2025)

4.1.2 Global Medicines for Alzheimer Disease Treatment Sales by Type (2026-2031)

4.1.3 Global Medicines for Alzheimer Disease Treatment Sales Market Share by Type (2020-2031)

4.2 Global Medicines for Alzheimer Disease Treatment Revenue by Type (2020-2031)

4.2.1 Global Medicines for Alzheimer Disease Treatment Revenue by Type (2020-2025)

4.2.2 Global Medicines for Alzheimer Disease Treatment Revenue by Type (2026-2031)

4.2.3 Global Medicines for Alzheimer Disease Treatment Revenue Market Share by Type (2020-2031)

4.3 Global Medicines for Alzheimer Disease Treatment Price by Type (2020-2031)

5 Segment by Application

5.1 Global Medicines for Alzheimer Disease Treatment Sales by Application (2020-2031)

5.1.1 Global Medicines for Alzheimer Disease Treatment Sales by Application (2020-2025)

5.1.2 Global Medicines for Alzheimer Disease Treatment Sales by Application (2026-2031)

5.1.3 Global Medicines for Alzheimer Disease Treatment Sales Market Share by Application (2020-2031)

5.2 Global Medicines for Alzheimer Disease Treatment Revenue by Application (2020-2031)

5.2.1 Global Medicines for Alzheimer Disease Treatment Revenue by Application (2020-2025)

5.2.2 Global Medicines for Alzheimer Disease Treatment Revenue by Application (2026-2031)

5.2.3 Global Medicines for Alzheimer Disease Treatment Revenue Market Share by Application (2020-2031)

5.3 Global Medicines for Alzheimer Disease Treatment Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Daiichi Sankyo Company Limited

6.1.1 Daiichi Sankyo Company Limited Company Information

6.1.2 Daiichi Sankyo Company Limited Description and Business Overview

6.1.3 Daiichi Sankyo Company Limited Medicines for Alzheimer Disease Treatment Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Daiichi Sankyo Company Limited Medicines for Alzheimer Disease Treatment Product Portfolio

6.1.5 Daiichi Sankyo Company Limited Recent Developments/Updates

6.2 H. Lundbeck A/S

6.2.1 H. Lundbeck A/S Company Information

6.2.2 H. Lundbeck A/S Description and Business Overview

6.2.3 H. Lundbeck A/S Medicines for Alzheimer Disease Treatment Sales, Revenue and Gross Margin (2020-2025)

6.2.4 H. Lundbeck A/S Medicines for Alzheimer Disease Treatment Product Portfolio

6.2.5 H. Lundbeck A/S Recent Developments/Updates

6.3 Novartis AG

6.3.1 Novartis AG Company Information

6.3.2 Novartis AG Description and Business Overview

6.3.3 Novartis AG Medicines for Alzheimer Disease Treatment Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Novartis AG Medicines for Alzheimer Disease Treatment Product Portfolio

6.3.5 Novartis AG Recent Developments/Updates

6.4 Lupin Pharmaceuticals, Inc

6.4.1 Lupin Pharmaceuticals, Inc Company Information

6.4.2 Lupin Pharmaceuticals, Inc Description and Business Overview

6.4.3 Lupin Pharmaceuticals, Inc Medicines for Alzheimer Disease Treatment Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Lupin Pharmaceuticals, Inc Medicines for Alzheimer Disease Treatment Product Portfolio

6.4.5 Lupin Pharmaceuticals, Inc Recent Developments/Updates

6.5 Actiza Pharmaceutical Private Limited

6.5.1 Actiza Pharmaceutical Private Limited Company Information

6.5.2 Actiza Pharmaceutical Private Limited Description and Business Overview

6.5.3 Actiza Pharmaceutical Private Limited Medicines for Alzheimer Disease Treatment Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Actiza Pharmaceutical Private Limited Medicines for Alzheimer Disease Treatment Product Portfolio

6.5.5 Actiza Pharmaceutical Private Limited Recent Developments/Updates

6.6 Amneal Pharmaceuticals LLC

6.6.1 Amneal Pharmaceuticals LLC Company Information

6.6.2 Amneal Pharmaceuticals LLC Description and Business Overview

6.6.3 Amneal Pharmaceuticals LLC Medicines for Alzheimer Disease Treatment Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Amneal Pharmaceuticals LLC Medicines for Alzheimer Disease Treatment Product Portfolio

6.6.5 Amneal Pharmaceuticals LLC Recent Developments/Updates

6.7 AC Immune

6.7.1 AC Immune Company Information

6.7.2 AC Immune Description and Business Overview

6.7.3 AC Immune Medicines for Alzheimer Disease Treatment Sales, Revenue and Gross Margin (2020-2025)

6.7.4 AC Immune Medicines for Alzheimer Disease Treatment Product Portfolio

6.7.5 AC Immune Recent Developments/Updates

6.8 F. Hoffmann-La Roche Ltd

6.8.1 F. Hoffmann-La Roche Ltd Company Information

6.8.2 F. Hoffmann-La Roche Ltd Description and Business Overview

6.8.3 F. Hoffmann-La Roche Ltd Medicines for Alzheimer Disease Treatment Sales, Revenue and Gross Margin (2020-2025)

6.8.4 F. Hoffmann-La Roche Ltd Medicines for Alzheimer Disease Treatment Product Portfolio

6.8.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates

6.9 Janssen Global Services, LLC

6.9.1 Janssen Global Services, LLC Company Information

6.9.2 Janssen Global Services, LLC Description and Business Overview

6.9.3 Janssen Global Services, LLC Medicines for Alzheimer Disease Treatment Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Janssen Global Services, LLC Medicines for Alzheimer Disease Treatment Product Portfolio

6.9.5 Janssen Global Services, LLC Recent Developments/Updates

6.10 AbbVie Inc

6.10.1 AbbVie Inc Company Information

6.10.2 AbbVie Inc Description and Business Overview

6.10.3 AbbVie Inc Medicines for Alzheimer Disease Treatment Sales, Revenue and Gross Margin (2020-2025)

6.10.4 AbbVie Inc Medicines for Alzheimer Disease Treatment Product Portfolio

6.10.5 AbbVie Inc Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Medicines for Alzheimer Disease Treatment Industry Chain Analysis

7.2 Medicines for Alzheimer Disease Treatment Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Medicines for Alzheimer Disease Treatment Production Mode & Process Analysis

7.4 Medicines for Alzheimer Disease Treatment Sales and Marketing

7.4.1 Medicines for Alzheimer Disease Treatment Sales Channels

7.4.2 Medicines for Alzheimer Disease Treatment Distributors

7.5 Medicines for Alzheimer Disease Treatment Customer Analysis

8 Medicines for Alzheimer Disease Treatment Market Dynamics

8.1 Medicines for Alzheimer Disease Treatment Industry Trends

8.2 Medicines for Alzheimer Disease Treatment Market Drivers

8.3 Medicines for Alzheimer Disease Treatment Market Challenges

8.4 Medicines for Alzheimer Disease Treatment Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Daiichi Sankyo Company Limited

H Lundbeck A S

Novartis

Lupin Pharmaceuticals, Inc

Actiza Pharmaceutical Private Limited

Amneal Pharmaceuticals LLC

AC Immune

F Hoffmann La Roche Ltd

Janssen Global Services, LLC

AbbVie

List of Tables

Table 1. Global Medicines for Alzheimer Disease Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Medicines for Alzheimer Disease Treatment Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Medicines for Alzheimer Disease Treatment Market Competitive Situation by Manufacturers in 2024

Table 4. Global Medicines for Alzheimer Disease Treatment Sales (Tons) of Key Manufacturers (2020-2025)

Table 5. Global Medicines for Alzheimer Disease Treatment Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Medicines for Alzheimer Disease Treatment Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Medicines for Alzheimer Disease Treatment Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Medicines for Alzheimer Disease Treatment Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Medicines for Alzheimer Disease Treatment, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Medicines for Alzheimer Disease Treatment, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Medicines for Alzheimer Disease Treatment, Product Type & Application

Table 12. Global Key Manufacturers of Medicines for Alzheimer Disease Treatment, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Medicines for Alzheimer Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicines for Alzheimer Disease Treatment as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Medicines for Alzheimer Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Medicines for Alzheimer Disease Treatment Sales by Region (2020-2025) & (Tons)

Table 18. Global Medicines for Alzheimer Disease Treatment Sales Market Share by Region (2020-2025)

Table 19. Global Medicines for Alzheimer Disease Treatment Sales by Region (2026-2031) & (Tons)

Table 20. Global Medicines for Alzheimer Disease Treatment Sales Market Share by Region (2026-2031)

Table 21. Global Medicines for Alzheimer Disease Treatment Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Medicines for Alzheimer Disease Treatment Revenue Market Share by Region (2020-2025)

Table 23. Global Medicines for Alzheimer Disease Treatment Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Medicines for Alzheimer Disease Treatment Revenue Market Share by Region (2026-2031)

Table 25. North America Medicines for Alzheimer Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Medicines for Alzheimer Disease Treatment Sales by Country (2020-2025) & (Tons)

Table 27. North America Medicines for Alzheimer Disease Treatment Sales by Country (2026-2031) & (Tons)

Table 28. North America Medicines for Alzheimer Disease Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Medicines for Alzheimer Disease Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Medicines for Alzheimer Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Medicines for Alzheimer Disease Treatment Sales by Country (2020-2025) & (Tons)

Table 32. Europe Medicines for Alzheimer Disease Treatment Sales by Country (2026-2031) & (Tons)

Table 33. Europe Medicines for Alzheimer Disease Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Medicines for Alzheimer Disease Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Medicines for Alzheimer Disease Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Medicines for Alzheimer Disease Treatment Sales by Region (2020-2025) & (Tons)

Table 37. Asia Pacific Medicines for Alzheimer Disease Treatment Sales by Region (2026-2031) & (Tons)

Table 38. Asia Pacific Medicines for Alzheimer Disease Treatment Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Medicines for Alzheimer Disease Treatment Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Medicines for Alzheimer Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Medicines for Alzheimer Disease Treatment Sales by Country (2020-2025) & (Tons)

Table 42. Latin America Medicines for Alzheimer Disease Treatment Sales by Country (2026-2031) & (Tons)

Table 43. Latin America Medicines for Alzheimer Disease Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Medicines for Alzheimer Disease Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Medicines for Alzheimer Disease Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Medicines for Alzheimer Disease Treatment Sales by Country (2020-2025) & (Tons)

Table 47. Middle East and Africa Medicines for Alzheimer Disease Treatment Sales by Country (2026-2031) & (Tons)

Table 48. Middle East and Africa Medicines for Alzheimer Disease Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Medicines for Alzheimer Disease Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Medicines for Alzheimer Disease Treatment Sales (Tons) by Type (2020-2025)

Table 51. Global Medicines for Alzheimer Disease Treatment Sales (Tons) by Type (2026-2031)

Table 52. Global Medicines for Alzheimer Disease Treatment Sales Market Share by Type (2020-2025)

Table 53. Global Medicines for Alzheimer Disease Treatment Sales Market Share by Type (2026-2031)

Table 54. Global Medicines for Alzheimer Disease Treatment Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Medicines for Alzheimer Disease Treatment Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Medicines for Alzheimer Disease Treatment Revenue Market Share by Type (2020-2025)

Table 57. Global Medicines for Alzheimer Disease Treatment Revenue Market Share by Type (2026-2031)

Table 58. Global Medicines for Alzheimer Disease Treatment Price (US$/Ton) by Type (2020-2025)

Table 59. Global Medicines for Alzheimer Disease Treatment Price (US$/Ton) by Type (2026-2031)

Table 60. Global Medicines for Alzheimer Disease Treatment Sales (Tons) by Application (2020-2025)

Table 61. Global Medicines for Alzheimer Disease Treatment Sales (Tons) by Application (2026-2031)

Table 62. Global Medicines for Alzheimer Disease Treatment Sales Market Share by Application (2020-2025)

Table 63. Global Medicines for Alzheimer Disease Treatment Sales Market Share by Application (2026-2031)

Table 64. Global Medicines for Alzheimer Disease Treatment Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Medicines for Alzheimer Disease Treatment Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Medicines for Alzheimer Disease Treatment Revenue Market Share by Application (2020-2025)

Table 67. Global Medicines for Alzheimer Disease Treatment Revenue Market Share by Application (2026-2031)

Table 68. Global Medicines for Alzheimer Disease Treatment Price (US$/Ton) by Application (2020-2025)

Table 69. Global Medicines for Alzheimer Disease Treatment Price (US$/Ton) by Application (2026-2031)

Table 70. Daiichi Sankyo Company Limited Company Information

Table 71. Daiichi Sankyo Company Limited Description and Business Overview

Table 72. Daiichi Sankyo Company Limited Medicines for Alzheimer Disease Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Daiichi Sankyo Company Limited Medicines for Alzheimer Disease Treatment Product

Table 74. Daiichi Sankyo Company Limited Recent Developments/Updates

Table 75. H. Lundbeck A/S Company Information

Table 76. H. Lundbeck A/S Description and Business Overview

Table 77. H. Lundbeck A/S Medicines for Alzheimer Disease Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. H. Lundbeck A/S Medicines for Alzheimer Disease Treatment Product

Table 79. H. Lundbeck A/S Recent Developments/Updates

Table 80. Novartis AG Company Information

Table 81. Novartis AG Description and Business Overview

Table 82. Novartis AG Medicines for Alzheimer Disease Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Novartis AG Medicines for Alzheimer Disease Treatment Product

Table 84. Novartis AG Recent Developments/Updates

Table 85. Lupin Pharmaceuticals, Inc Company Information

Table 86. Lupin Pharmaceuticals, Inc Description and Business Overview

Table 87. Lupin Pharmaceuticals, Inc Medicines for Alzheimer Disease Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Lupin Pharmaceuticals, Inc Medicines for Alzheimer Disease Treatment Product

Table 89. Lupin Pharmaceuticals, Inc Recent Developments/Updates

Table 90. Actiza Pharmaceutical Private Limited Company Information

Table 91. Actiza Pharmaceutical Private Limited Description and Business Overview

Table 92. Actiza Pharmaceutical Private Limited Medicines for Alzheimer Disease Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Actiza Pharmaceutical Private Limited Medicines for Alzheimer Disease Treatment Product

Table 94. Actiza Pharmaceutical Private Limited Recent Developments/Updates

Table 95. Amneal Pharmaceuticals LLC Company Information

Table 96. Amneal Pharmaceuticals LLC Description and Business Overview

Table 97. Amneal Pharmaceuticals LLC Medicines for Alzheimer Disease Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Amneal Pharmaceuticals LLC Medicines for Alzheimer Disease Treatment Product

Table 99. Amneal Pharmaceuticals LLC Recent Developments/Updates

Table 100. AC Immune Company Information

Table 101. AC Immune Description and Business Overview

Table 102. AC Immune Medicines for Alzheimer Disease Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. AC Immune Medicines for Alzheimer Disease Treatment Product

Table 104. AC Immune Recent Developments/Updates

Table 105. F. Hoffmann-La Roche Ltd Company Information

Table 106. F. Hoffmann-La Roche Ltd Description and Business Overview

Table 107. F. Hoffmann-La Roche Ltd Medicines for Alzheimer Disease Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. F. Hoffmann-La Roche Ltd Medicines for Alzheimer Disease Treatment Product

Table 109. F. Hoffmann-La Roche Ltd Recent Developments/Updates

Table 110. Janssen Global Services, LLC Company Information

Table 111. Janssen Global Services, LLC Description and Business Overview

Table 112. Janssen Global Services, LLC Medicines for Alzheimer Disease Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Janssen Global Services, LLC Medicines for Alzheimer Disease Treatment Product

Table 114. Janssen Global Services, LLC Recent Developments/Updates

Table 115. AbbVie Inc Company Information

Table 116. AbbVie Inc Description and Business Overview

Table 117. AbbVie Inc Medicines for Alzheimer Disease Treatment Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. AbbVie Inc Medicines for Alzheimer Disease Treatment Product

Table 119. AbbVie Inc Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Medicines for Alzheimer Disease Treatment Distributors List

Table 123. Medicines for Alzheimer Disease Treatment Customers List

Table 124. Medicines for Alzheimer Disease Treatment Market Trends

Table 125. Medicines for Alzheimer Disease Treatment Market Drivers

Table 126. Medicines for Alzheimer Disease Treatment Market Challenges

Table 127. Medicines for Alzheimer Disease Treatment Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Medicines for Alzheimer Disease Treatment

Figure 2. Global Medicines for Alzheimer Disease Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Medicines for Alzheimer Disease Treatment Market Share by Type: 2024 & 2031

Figure 4. NMDA Receptor Antagonists Product Picture

Figure 5. Cholinesterase Inhibitors Product Picture

Figure 6. Global Medicines for Alzheimer Disease Treatment Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Medicines for Alzheimer Disease Treatment Market Share by Application: 2024 & 2031

Figure 8. Hospital Pharmacy

Figure 9. Retail Pharmacy

Figure 10. Online Pharmacy

Figure 11. Global Medicines for Alzheimer Disease Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Medicines for Alzheimer Disease Treatment Market Size (2020-2031) & (US$ Million)

Figure 13. Global Medicines for Alzheimer Disease Treatment Sales (2020-2031) & (Tons)

Figure 14. Global Medicines for Alzheimer Disease Treatment Average Price (US$/Ton) & (2020-2031)

Figure 15. Medicines for Alzheimer Disease Treatment Report Years Considered

Figure 16. Medicines for Alzheimer Disease Treatment Sales Share by Manufacturers in 2024

Figure 17. Global Medicines for Alzheimer Disease Treatment Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Medicines for Alzheimer Disease Treatment Players: Market Share by Revenue in Medicines for Alzheimer Disease Treatment in 2024

Figure 19. Medicines for Alzheimer Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Medicines for Alzheimer Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Medicines for Alzheimer Disease Treatment Sales Market Share by Country (2020-2031)

Figure 22. North America Medicines for Alzheimer Disease Treatment Revenue Market Share by Country (2020-2031)

Figure 23. United States Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Medicines for Alzheimer Disease Treatment Sales Market Share by Country (2020-2031)

Figure 26. Europe Medicines for Alzheimer Disease Treatment Revenue Market Share by Country (2020-2031)

Figure 27. Germany Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Medicines for Alzheimer Disease Treatment Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Medicines for Alzheimer Disease Treatment Revenue Market Share by Region (2020-2031)

Figure 34. China Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Medicines for Alzheimer Disease Treatment Sales Market Share by Country (2020-2031)

Figure 44. Latin America Medicines for Alzheimer Disease Treatment Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Medicines for Alzheimer Disease Treatment Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Medicines for Alzheimer Disease Treatment Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Medicines for Alzheimer Disease Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Medicines for Alzheimer Disease Treatment by Type (2020-2031)

Figure 54. Global Revenue Market Share of Medicines for Alzheimer Disease Treatment by Type (2020-2031)

Figure 55. Global Medicines for Alzheimer Disease Treatment Price (US$/Ton) by Type (2020-2031)

Figure 56. Global Sales Market Share of Medicines for Alzheimer Disease Treatment by Application (2020-2031)

Figure 57. Global Revenue Market Share of Medicines for Alzheimer Disease Treatment by Application (2020-2031)

Figure 58. Global Medicines for Alzheimer Disease Treatment Price (US$/Ton) by Application (2020-2031)

Figure 59. Medicines for Alzheimer Disease Treatment Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Still s Disease Treatment Market Research Report 2025

Global Tauopathies Treatment Market Research Report 2025

Global Treatment Planning Software Market Research Report 2025

Global Combination Therapy Drug Market Research Report 2025

Global Pharmaceutical Asset Management Market Research Report 2025

Global Autoimmune Diseases Treatment Market Research Report 2024

Global Drugs of Abuse Testing Market Research Report 2024

Global Pill Organizer with Timer Reminder Market Research Report 2025

Global AI Image assisted Diagnosis Software Market Research Report 2025

Global Alzheimer s Drugs Market Research Report 2025

Global Alzheimer s Treatment Drug Market Research Report 2024

Alzheimer Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alzheimer s Therapeutic Market Research Report 2024

Global Alzheimer s Clinical Treatment Drug Market Research Report 2025

Alzheimer Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cardiovascular Disease Nursing Drugs Market Research Report 2025

Global Pharmerging Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions